Annual report pursuant to Section 13 and 15(d)

Net Loss Per Share (Tables)

v3.24.1
Net Loss Per Share (Tables)
 12 Months Ended
Dec. 31, 2023
Earnings Per Share [Abstract]  
Schedule of Net Loss Per Share, Basic and Diluted
The following table sets forth the computation of the Company's net loss per share attributable to common stockholders:
 
  Year Ended December 31,
(in thousands, except share and per share data)(1)
  2023 2022
Net loss
 $ (124,015) $ (111,071)
Weighted average common stock outstanding, basic and diluted
 7,943,874  6,701,126 
Net loss per common share, basic and diluted
 $ (15.61) $ (16.57)
_____________________

(1) Share and per share amounts have been retroactively adjusted to reflect the June 15, 2023 Reverse Stock Split. See Note 12, Stockholders' Equity, for additional detail.
Schedule of Antidilutive Securities Excluded from Computation of Net Loss Per Share
The following table discloses the weighted-average shares outstanding of securities that could potentially dilute basic net loss per share in the future that were not included in the computation of diluted net loss per share as the impact would be anti-dilutive:
  Year Ended December 31,
  2023 2022
Restricted Stock(1)
222,282  388,210 
Warrants(2)
4,980,021  887,636 
_____________________

(1) Share amounts have been retroactively adjusted to reflect the June 15, 2023 Reverse Stock Split. See Note 12, Stockholders' Equity, for additional detail.

(2) Subsequent to the Reverse Stock Split, every 13 common shares under warrants becomes exercisable for one share of common stock at an exercise price of $149.50 per share of common stock for the Company's 2021 warrants and $13.00 per share of common stock for the March 2023 Cargill Warrant, which is reflected in the table above. See Note 12, Stockholders' Equity, for additional detail.